Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zosano Pharma (ZSAN)

Zosano Pharma (ZSAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,491
  • Shares Outstanding, K 18,231
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,360 K
  • 60-Month Beta 2.61
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.36
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.89
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.85
  • Growth Rate Est. (year over year) +117,629.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.53 +40.68%
on 02/12/20
1.47 -49.73%
on 01/22/20
-0.71 (-48.97%)
since 01/21/20
3-Month
0.53 +40.68%
on 02/12/20
1.97 -62.44%
on 12/02/19
-0.95 (-56.21%)
since 11/21/19
52-Week
0.53 +40.68%
on 02/12/20
6.20 -88.06%
on 02/22/19
-5.26 (-87.67%)
since 02/21/19

Most Recent Stories

More News
Zosano Pharma Announces Pricing of $8.0 Million Public Offering of Common Stock and Warrants

Zosano Pharma Corporation (Nasdaq:ZSAN) (the "Company" or "Zosano"), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of...

ZSAN : 0.74 (-7.50%)
Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it is commencing an underwritten public offering of units consisting of shares of common stock...

ZSAN : 0.74 (-7.50%)
Zosano Announces FDA Submission of New Drug Application for Qtrypta

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the submission of a 505(b)(2) New Drug Application ("NDA") for Qtrypta(TM) to the U.S. Food and Drug...

ZSAN : 0.74 (-7.50%)
Zosano Announces Pricing of Registered Direct Offering

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase agreement with several institutional investors providing...

ZSAN : 0.74 (-7.50%)
Zosano Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2019, as well as recent business highlights....

ZSAN : 0.74 (-7.50%)
Zosano Pharma Announces Completion of Pre-NDA Meetings with FDA for Qtrypta(TM)

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has received minutes from pre- New Drug Application ("NDA") meetings with the Food and Drug...

ZSAN : 0.74 (-7.50%)
Zosano Pharma to Host Conference Call on Third Quarter 2019 Financial Results and Provide Operational Update

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and webcast on Thursday, November 14, 2019 at 4:30 p.m. ET to discuss...

ZSAN : 0.74 (-7.50%)
Zosano Pharma Initiates Phase 2/3 Clinical Study in Cluster Headache

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has begun enrolling cluster headache patients in the ATAC clinical trial. This Phase...

ZSAN : 0.74 (-7.50%)
Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock option to purchase 450,000 shares of Zosano's common stock...

ZSAN : 0.74 (-7.50%)
Zosano Pharma Announces CEO Transition

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that Steven Lo, veteran biotechnology and pharmaceutical executive, will become president and chief...

ZSAN : 0.74 (-7.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ZSAN with:

Business Summary

Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe...

See More

Key Turning Points

2nd Resistance Point 0.81
1st Resistance Point 0.77
Last Price 0.74
1st Support Level 0.72
2nd Support Level 0.71

See More

52-Week High 6.20
Fibonacci 61.8% 4.03
Fibonacci 50% 3.36
Fibonacci 38.2% 2.69
Last Price 0.74
52-Week Low 0.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar